2024 Global Polyclonal Antibodies Market Report: Key Drivers, Size, and Leading Segments
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Growth Rate is Predicted for the Polyclonal Antibodies Market for 2024-2033?
There has been a significant growth in the polyclonal antibodies market size in the past few years. The market is predicted to expand from $1.35 billion in 2023 to $1.43 billion in 2024, reflecting a compound annual growth rate (CAGR) of 6.2%. Factors such as the surge in demand for biomedical research, the rise in diagnostic applications, an increase in chronic diseases, and a broad scope of applications contributed to the growth during the historical period.
There is a prediction for significant expansion in the polyclonal antibodies market, with projections estimating it will reach a value of $1.83 billion by 2028, exhibiting a compound annual growth rate (CAGR) of 6.4%. This increase during the forecast period is likely due to a combination of factors including the progression of diagnostic technology, therapeutic improvements, a surge in infectious diseases, augmented funding for research, as well as collaborations and partnerships. Top trends anticipated in this forecast period involve advancements in antibody engineering and its increasing role in cancer immunotherapy, the emergence of biosimilar polyclonal antibodies, application in treating neurological disorders, and improvements in regulatory and compliance procedures.
Claim Your Free Sample of the Global Polyclonal Antibodies Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10790&type=smp
What Drivers Are Enhancing the polyclonal antibodies Market’s Growth?
The rising incidence of cancer is likely to spur the expansion of the polyclonal antibodies market. Used for biomarker detection, immunohistochemistry, targeted therapy, and immunotherapy in cancer research and treatment, polyclonal antibodies enhance cancer diagnosis, treatment, and patient outcomes. The surge in cancer patients contributes to the polyclonal antibodies market’s growth. For example, in September 2022, Cancer Australia, a cancer control organization in Australia, estimated that 2,572 new stomach cancer cases (1,661 male and 911 female) would be diagnosed in 2022. Their data also revealed that by the age of 85 in 2022, there’s a 1 in 114 (or 0.87%) likelihood of contracting stomach cancer (1 in 1.1 or 87% for men and 1 in 167 or 0.60% for women). Hence, the escalating prevalence of cancer is boosting the growth of the polyclonal antibodies market.
What Segments Are Central to the Polyclonal Antibodies Market?
1) By Product Type: Primary Antibody, Secondary Antibody
2) By Source: Rabbits, Goats, Sheep, Other Sources
3) By Application: Research, Diagnostics, Therapy
4) By End-User: Academic and Research Center , Pharmaceutical and Biotechnology Companies, Diagnostic Centers , Hospitals
What Emerging Trends Are Influencing Polyclonal Antibodies Industry Dynamics?
In the polyclonal antibodies market, the key trend that is gaining ground is research and development. This is being heavily pursued by the main companies in this field in order to enhance their ability to make observations and to maintain their market position. For example, in July 2022, GigaGen Inc., a biotechnology company based in the US, published a research paper in the international, peer-reviewed journal Pathogens titled ‘GMP manufacturing and IND-enabling studies of a recombinant hyperimmune globulin targeting SARS-CoV-2’. This paper presents, for the first time, the company’s recombinant polyclonal product GIGA-2050, which targets SARS-CoV-2, along with the GMP production and the IND-enabling investigation of its novel type of pharmaceuticals, recombinant polyclonal antibodies. The paper reveals that GIGA-2050 consists of over 12,000 antibodies from a single master cell bank (MCB). This contrasts with the manufacturing processes before GIGA-2050, which typically created separate MCBs for each monoclonal antibody and mixed the MCBs prior to production.
Order Now for Fast Delivery of Your Polyclonal Antibodies Market Report!
https://www.thebusinessresearchcompany.com/report/polyclonal-antibodies-global-market-report
Which Geographic Locations Are Critical to the Growth of the Polyclonal Antibodies Market?
North America was the largest region in the polyclonal antibodies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global polyclonal antibodies market size forecast period. The regions covered in the polyclonal antibodies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Polyclonal Antibodies Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the polyclonal antibodies market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Polyclonal Antibodies Market Include
1. Polyclonal Antibodies Market Executive Summary
2. Polyclonal Antibodies Market Segments
3. Polyclonal Antibodies Market Size And Template Market Growth Rate
4. Key Polyclonal Antibodies Market Trends
5. Major Polyclonal Antibodies Market Drivers
……
25. Key Mergers And Acquisitions In The Polyclonal Antibodies Market
26. Top Polyclonal Antibodies Companies
27. Polyclonal Antibodies Market Opportunities And Strategies
28. Polyclonal Antibodies Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Fatty Acids Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/fatty-acids-global-market-report
Secondary Batteries Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/secondary-batteries-global-market-report
Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
